PulseAugur
EN
LIVE 21:44:24

FDA Investigates Kratom Supplement Linked to ICU Admissions

By PulseAugur Editorial · [1 sources] ·

The FDA is investigating kratom, a natural supplement marketed for over a decade, due to its potential to cause serious health issues. Kratom contains compounds that interact with opioid receptors, leading to concerns about its safety and potential for misuse. The agency is collecting data to assess the risks associated with its consumption. AI

IMPACT This investigation highlights the challenges in regulating natural supplements and the potential health risks associated with products interacting with opioid receptors.

RANK_REASON The FDA is investigating a supplement based on reported adverse events, which falls under regulatory and safety research. [lever_c_demoted from research: ic=1 ai=0.4]

Read on Forbes — Innovation →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

FDA Investigates Kratom Supplement Linked to ICU Admissions

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Tool
The FDA is investigating a supplement based on reported adverse events, which falls under regulatory and safety research. [lever_c_demoted from research: ic=1 ai=0.4]
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
safety, policy
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Standard
On-topic for AI-industry coverage; kept in the public index.
Story freshness
13 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. Forbes — Innovation TIER_1 English(EN) · Robert Glatter, MD, Contributor ·

    The ‘Natural’ Supplement Sending People To The ICU

    Marketed for over a decade as a natural wellness product, kratom contains mitragynine and its derivative 7-hydroxymitragynine, which both interact with opioid receptors.

RELATED ENTITIES

RELATED TOPICS